AG
ATRS

Advisor Group’s Antares Pharma, Inc. ATRS Stock Holding History

Advisor Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-250
Closed -$3K – 5105
2018
Q1 		$3K Buy
+250
New +$563 ﹤0.01% 4617

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Advisor Group's ATRS Position: Q4 2019 in Review

Advisor Group increased its Antares Pharma, Inc. (ATRS) stake by 11% in Q4 2019, buying an estimated $35.8K and bringing the position to 84,997 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Advisor Group first reported a position in ATRS in Q1 2017 and has held it in 12 quarters since. 160 funds tracked by Wall St. Rank hold ATRS as of Q4 2019.

  • Advisor Group held 84,997 shares of Antares Pharma, Inc. worth $399K as of Q4 2019.
  • Advisor Group bought 8,749 Antares Pharma, Inc. shares in Q4 2019, an estimated $35.8K.
  • Antares Pharma, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1839 holding.
  • Advisor Group first reported a position in Antares Pharma, Inc. in Q1 2017 and has held it in 12 quarters since.
  • 160 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.